C50H55ClN10O7 — CID 155235843
N-[7-[4-[3-[(3R)-3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]piperidine-1-carbonyl]phenyl]piperazin-1-yl]heptyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide (PubChem CID 155235843) has the molecular formula C50H55ClN10O7 and a molecular weight of 943.51 g/mol. Its IUPAC name is N-[7-[4-[3-[(3R)-3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]piperidine-1-carbonyl]phenyl]piperazin-1-yl]heptyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide.
| Compound Name | N-[7-[4-[3-[(3R)-3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]piperidine-1-carbonyl]phenyl]piperazin-1-yl]heptyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide |
|---|---|
| PubChem CID | 155235843 |
| Molecular Formula | C50H55ClN10O7 |
| Molecular Weight | 943.51 g/mol |
| Exact Mass | 942.39 |
| IUPAC Name | N-[7-[4-[3-[(3R)-3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]piperidine-1-carbonyl]phenyl]piperazin-1-yl]heptyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide |
| SMILES | O=C(COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCCCCCN1CCN(c2cccc(C(=O)N3CCC[C@@H](Nc4ncc(Cl)c(-c5c[nH]c6ccccc56)n4)C3)c2)CC1 |
| InChI | InChI=1S/C50H55ClN10O7/c51-38-29-54-50(57-45(38)37-28-53-39-16-5-4-14-35(37)39)55-33-12-10-22-60(30-33)47(65)32-11-8-13-34(27-32)59-25-23-58(24-26-59)21-7-3-1-2-6-20-52-43(63)31-68-41-17-9-15-36-44(41)49(67)61(48(36)66)40-18-19-42(62)56-46(40)64/h4-5,8-9,11,13-17,27-29,33,40,53H,1-3,6-7,10,12,18-26,30-31H2,(H,52,63)(H,54,55,57)(H,56,62,64)/t33-,40?/m1/s1 |
| InChIKey | YRFGPTSNMIUETO-DGRXGLRRSA-N |
| XLogP | 5.66 |
| TPSA | 202.27 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 68 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 943.51 |
| LogP ≤ 5 | 5.66 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|